Interleukin-1 inhibitors for acute gout

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of interleukin-1 inhibitors (anakinra, canakinumab, rilonacept) in acute gout.

Ancillary